EXOPHARM LIMITED

Press Releases Exopharm Limited

Equities

EX1

AU0000030975

Delayed Australian S.E. Other stock markets 08:10:45 2023-10-01 pm EDT			5-day change	1st Jan Change
0.0275 ^AUD	+10.00%		-.--%	-.--%

Feb. 26	Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Exopharm to Cut CEO Role Amid Cost Reductions	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exopharm : Appendix 4D and Half Year Report for period 31 December 2021	22-02-25	PU
Exopharm : Response to ASX Query	22-02-03	PU
Exopharm : Independent Plexaris and Cevaris testing shows positive and unique results	20-02-13	AQ
Exopharm : First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study	20-01-29	BU
Exopharm : Backs Regulatory Crackdown on Unapproved Exosome Products	19-12-19	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer